HS
SGMO

Haafor (Singapore)’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Haafor (Singapore)’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-12,659
Closed -$113K – 236
2020
Q2 		$113K Buy
+12,659
New +$117K 0.19% 144

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Haafor (Singapore)'s SGMO Position: Q3 2020 in Review

Haafor (Singapore) sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2020, closing a stake of 12,659 shares — an estimated $113K sold.

Haafor (Singapore) first reported a position in SGMO in Q2 2020 and held it in 1 quarter. The position peaked at $113K in Q2 2020. 210 funds tracked by Wall St. Rank hold SGMO as of Q3 2020.

  • Haafor (Singapore) reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2020 after selling out during the quarter.
  • Haafor (Singapore) sold 12,659 SANGAMO THERAPEUTICS INC shares in Q3 2020, an estimated $113K.
  • Haafor (Singapore) first reported a position in SANGAMO THERAPEUTICS INC in Q2 2020 and held it in 1 quarter.
  • Haafor (Singapore)'s SANGAMO THERAPEUTICS INC position peaked at $113K in Q2 2020.
  • 210 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2020.

Based on Haafor (Singapore)'s 13F filing for Q3 2020, filed 16 Nov 2020.